Australia - engelsk - Department of Health (Therapeutic Goods Administration)

pharmacare laboratories pty ltd - zinc sulfate monohydrate, quantity: 6.86 mg (equivalent: zinc, qty 2.5 mg); ascorbic acid, quantity: 30 mg - pastille - excipient ingredients: curcuma longa; potable water; liquid glucose; gelatin; sucrose; citric acid; flavour - antioxidant/reduce free radicals formed in the body ; maintain/support healthy growth and development ; maintain/support general health and wellbeing ; maintain/support immune system health ; maintain/support healthy immune system function ; maintain/support (state vitamin/mineral/nutrient) levels in the body

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

pharmacare laboratories pty ltd - ascorbic acid, quantity: 30 mg; zinc sulfate monohydrate, quantity: 6.86 mg (equivalent: zinc, qty 2.5 mg) - pastille - excipient ingredients: carnauba wax; glycerol; sucrose; gelatin; liquid glucose; medium chain triglycerides; citric acid; vegetable oil; purified water; flavour; colour - antioxidant/reduce free radicals formed in the body ; maintain/support healthy growth and development ; maintain/support general health and wellbeing ; maintain/support immune system health ; maintain/support healthy immune system function ; maintain/support (state vitamin/mineral/nutrient) levels in the body

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

pharmacare laboratories pty ltd - ascorbic acid, quantity: 30 mg; zinc sulfate monohydrate, quantity: 6.86 mg (equivalent: zinc, qty 2.5 mg) - pastille - excipient ingredients: gelatin; sucrose; liquid glucose; potable water; citric acid; curcumin; flavour - antioxidant/reduce free radicals formed in the body ; maintain/support healthy growth and development ; maintain/support general health and wellbeing ; maintain/support immune system health ; maintain/support healthy immune system function ; maintain/support (state vitamin/mineral/nutrient) levels in the body

Hellas - gresk - Εθνικός Οργανισμός Φαρμάκων

nassington ltd, cyprus Ιπποκράτους 3Α,, 2006 Λευκωσία - zinc sulfate monohydrate - oral.sol (ΠΟΣΙΜΟ ΔΙΑΛΥΜΑ) - 45mg/5ml - zinc sulfate monohydrate 25mg - zinc sulfate

Hellas - gresk - Εθνικός Οργανισμός Φαρμάκων

nassington ltd, cyprus Ιπποκράτους 3Α,, 2006 Λευκωσία - zinc sulfate monohydrate - solu.tab (ΔΙΑΛΥΤΟ ΔΙΣΚΙΟ) - 45mg/tab - zinc sulfate monohydrate 125mg - zinc sulfate

USA - engelsk - NLM (National Library of Medicine)

hospira, inc. - zinc chloride (unii: 86q357l16b) (zinc cation - unii:13s1s8sf37) - zinc cation 1 mg in 1 ml - zinc 1 mg/ml (zinc chloride injection, usp) is indicated for use as a supplement to intravenous solutions given for total parenteral nutrition. administration helps to maintain zinc serum levels and to prevent depletion of endogenous stores, and subsequent deficiency symptoms. none known. none known.

USA - engelsk - NLM (National Library of Medicine)

american regent, inc. - zinc sulfate anhydrous (unii: 0j6z13x3wo) (zinc cation - unii:13s1s8sf37) - zinc cation 1 mg in 1 ml - zinc sulfate injection, usp is indicated for use as a supplement to intravenous solutions given for tpn. administration helps to maintain plasma levels and to prevent depletion of endogenous stores. zinc sulfate injection, usp should not be given undiluted by direct injection into a peripheral vein because of the likelihood of infusion phlebitis and the potential to increase renal loss of zinc from a bolus injection.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - zinc chloride, quantity: 5.3 mg/ml - injection, solution - excipient ingredients: water for injections; hydrochloric acid - indications as at 01 jan 1991 : zinc chloride injection is intended for use as an additive to compatible intravenous fluids or total parenteral nutrition solutions. it is indicated for the prevention and treatment of zinc deficiency, which may be characterised by growth deterioration, skin lesions, alopecia, impaired reproductive development and function, and delayed or inhibited wound healing. indications as at 01 jan 1991 : zinc chloride injection is intended for use as an additive to compatible intravenous fluids or total parenteral nutrition solutions. it is indicated for the prevention and treatment of zinc deficiency, which may be characterised by growth deterioration, skin lesions, alopecia, impaired reproductive development and function, and delayed or inhibited wound healing.

Frankrike - fransk - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

laboratoire aguettant - zinc (gluconate de) 69 - solution - 69,7 mg - pour 10 ml > zinc (gluconate de 69,7 mg - autres supplements mineraux - classe pharmacothérapeutique : autres supplements mineraux, code atc a12cb02zinc injectable 1 mg/ml contient comme substance active le gluconate de zinc. il appartient à un groupe de compléments minéraux et fournit une source nutritionnelle de zinc. le zinc est un oligo-élément essentiel assurant une fonction métabolique efficace.zinc injectable 1 mg/ml est utilisé dans la prévention et le traitement lors de l’alimentation par voie parentérale (l'alimentation artificielle dans une veine).zinc injectable 1 mg/ml peut être utilisé chez l'adulte et chez l'enfant.le zinc est un oligo-élément, ce qui signifie que votre corps n’a besoin que d’une très faible quantité de ce nutriment. le zinc joue un rôle essentiel dans certains organes (le foie, le pancréas, le cerveau, les intestins), systèmes hormonaux et enzymatiques, et dans la lutte contre le risque d’infection (système immunitaire).le zinc occupe une place importante dans la croissance des bébés prématurés et des nourrissons et enfants nécessitant des soins accrus.

Kenya - engelsk - Pharmacy and Poisons Board

alkem laboratories 167/mahatma gandhi udyog nagar dabhel daman 396 - zinc sulfate tablets usp 20mg - dispersible tablet - zinc sulfate usp (as monohydrate) 54.88mg… - mineral supplements: zinc